Buprenorphine Option Did Not Improve Pain, Reduce Opioid Dosage
Patients prescribed high-dose opioids were given the option to switch to buprenorphine in hopes of improving pain and reducing opioid dosage.
FDA Accepts sBLA for Dupilumab for Bullous Pemphigoid
Previously, dupilumab (Dupixent) received orphan drug designation for bullous pemphigoid.
ICER Finds Insurers Struggled to Provide Fair Access to Obesity Drugs
The Institute for Clinical and Economic Review assessed the formularies of 11 payers, covering 57 million people, to determine access to drugs that the organization had reviewed for cost effectiveness in 2022.
Esketamine Safe, Effective for Treating Postoperative Pain
Researchers investigate the effects of subanesthetic doses of esketamine for the treatment of pain and cognition in patients undergoing surgery.
FDA Approves Recombinant Chikungunya Vaccine, Vimkunya
The vaccine is the first virus-like particle single-dose vaccine for chikungunya for patients 12 years and older.
Automated Insulin Delivery Significantly Lowered A1c for Patients With T2D
Among a diverse cohort of patients with type 2 diabetes (T2D), researchers examined the use of automated insulin delivery for lowering hemoglobin A1c levels.
FDA Approves Denosumab-Dssb as Biosimilar for Prolia, Xgeva
Denosumab-dssb is approved as a 60 mg pre-filled syringe as a biosimilar for Prolia and 120 mg vial as a biosimilar for Xgeva.
FDA Approves MenABCWY Vaccine for Patients Ages 10 to 25 Years
The combination includes 2 previously approved vaccines to target the 5 major serogroups of Neisseria meningitidis.
Vaccine Administration in Pharmacies, Nontraditional Clinics Could Help Increase Access
In order to meet national targets, the United States should expand vaccination administration in complementary sites like pharmacies.
New Test Could Help Identify Patients That Would Benefit From Blood Thinners
Currently, blood-thinning medications are only prescribed to patients who have already had a heart attack or stroke, as the drugs can cause serious bleeding.
FDA Approves Merilog as Biosimilar to Insulin Aspart for Diabetes
The drug is the first rapid-acting insulin biosimilar product approved for use by the FDA, marking a significant milestone in diabetes treatment.
Neuroactive Steroid Levels May Indicate Risk of Postpartum Depression
Identifying women who are at risk for postpartum depression sooner can lead to quicker and possibly preventative treatment.
Learning Sessions, Shared Decision Making Could Help Increase Vaccinations Among Older Adults
Among providers who took part in a recent study, 57% reported increased vaccination rates after implementing a quality improvement initiative.
E. Coli Vaccine Candidate Fails to Demonstrate Efficacy in Phase 3 Trial
Investigators note there were no safety signals related to the vaccine candidate, and participants who developed E. coli disease received treatment and care.
Focus on What Matters: Sustaining Your Pharmacy in 2025
What are some key strategies for keeping your pharmacy thriving in 2025?
FDA Grants Fast Track Designation to Cannabis Withdrawal Syndrome Therapy
A dose response is observed with the highest dose of the drug and mitigating withdrawal symptoms for patients with cannabis use disorder.
Keeping Focus on Bottom Line Amid Industrywide Changes in Pharmacy
Pharmacy industry experts gathered for a webinar detailing the upcoming trends expected to take shape in 2025.
2025 ACIP Immunization Schedules
More detailed information can be found on the CDC’s website at www.cdc.gov/vaccines.
Tirzepatide Facilitates Greater Weight Loss, Strongest Antihypertensive Effects
For weight loss and antihypertensive effects on systolic and diastolic blood pressure, semaglutide also had increased effects.
Pharmacists as the Authority on Ultra-High-Cost Drugs
Erin Fox, PharmD, MHA, BCPS, FASHP, joined Drug Topics to discuss ultra-high-cost drugs and the American Society of Health-System Pharmacists 2025 Pharmacy Forecast.
Q&A: How Will Suzetrigine Impact the Pain Management Landscape?
A discussion on the new nonopioid selective NaV1.8 pain signal inhibitor with Madison Irwin, PharmD, BCPS.
AI Haptic Feedback Technology Reduced Nocturnal Scratching in Atopic Dermatitis
For patients with atopic dermatitis reporting moderate-to-severe scratching, researchers explored the efficacy of an AI-enabled wearable sensor with closed-loop haptic feedback.
Prenatal Vitamins Help Reduce Risk of Giving Birth to Vulnerable Newborns
Multiple micronutrient supplements showed the greatest impact on reducing the risk of giving birth to small vulnerable newborns.
FDA Approves Risdiplam Tablet for Spinal Muscular Atrophy
The tablet formation of risdiplam (Evrysdi) demonstrates bioequivalence to the oral formulation of the drug.
FDA Grants Fast Track Designation to Amlenetug As Treatment for Multiple System Atrophy
The designation is based on the AMULET phase 2 trial, which was the first-in-human study of the drug.
In My View: Vigilant Citizens Should Be Celebrated, Not Vilified
Those who contributed to the arrest of Luigi Mangione, the suspect in the murder of UnitedHealthcare CEO Brian Thompson, are facing unjustified backlash. They are heroes—not snitches.
Healthy Cardiovascular System Associated with Increased Migraine Incidence
Cardiovascular health is known to be associated with the probability of having active or developing migraine in the future.
FDA Grants Fast Track Designation to Troculeucel for Moderate Alzheimer Disease
Data has shown the investigational cell therapy is well-tolerated in patients and showed preliminary impacts on cognition.
Male Patients With Diabetes, Obesity Have Poorer Prognosis of Thyroid Cancer
Recently, there has been concern around glucagon-like peptide-1 receptor agonists and increase the risk of thyroid cancer, with liraglutide having a black box warning label for the disease.
Q&A: How Barbershops Are Transforming Hypertension Management
Crystal Zhou, PharmD, APh, AHSCP, BCACP, discussed her role as Lead Pharmacist of the Cut Hypertension Program.
